With regard to the emerging role of lncRNA HAND2-AS1 as a promising and innovative prognostic, immunomodulatory, and therapeutic biomarker in CRC, we conducted a comprehensive investigation of its expression level in CRC tissues (n = 10) and adjacent normal tissues (n = 10) using RT-qPCR. The gene discussed is HAND2; the disease is colorectal carcinoma.